“Our aim is to provide doctors and patients with value adding pharmaceutical products to help reduce the risks and damages caused by addiction.”
Charlotte Haas, Chief Transformation Officer
We have become a leader in the treatment of opioid addiction in France and the United Kingdom during which time we have worked in close collaboration with governments, leading addiction treatment providers and healthcare professionals working in opioid addiction. It is this depth of expertise that makes us a market leader and a highly-trusted supplier of opioid addiction products.
We have developed a comprehensive range of medicines to support an individual’s recovery from opioid addiction. Our products include formulations of the three standard molecules in this therapy area; methadone, buprenorphine and naloxone.